- Home
- ENR vs PTGX Comparison
ENR vs PTGX Comparison
Compare ENR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENR
- PTGX
- Stock Information
- Founded
- ENR 2015
- PTGX 2006
- Country
- ENR United States
- PTGX United States
- Employees
- ENR N/A
- PTGX N/A
- Industry
- ENR Industrial Machinery/Components
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- ENR Miscellaneous
- PTGX Health Care
- Exchange
- ENR Nasdaq
- PTGX Nasdaq
- Market Cap
- ENR 1.5B
- PTGX 3.3B
- IPO Year
- ENR N/A
- PTGX 2016
- Fundamental
- Price
- ENR $22.75
- PTGX $53.00
- Analyst Decision
- ENR Hold
- PTGX Strong Buy
- Analyst Count
- ENR 8
- PTGX 9
- Target Price
- ENR $31.63
- PTGX $67.11
- AVG Volume (30 Days)
- ENR 1.2M
- PTGX 923.4K
- Earning Date
- ENR 08-05-2025
- PTGX 08-05-2025
- Dividend Yield
- ENR 5.26%
- PTGX N/A
- EPS Growth
- ENR N/A
- PTGX N/A
- EPS
- ENR 0.74
- PTGX 0.86
- Revenue
- ENR $2,901,700,000.00
- PTGX $207,801,000.00
- Revenue This Year
- ENR $1.77
- PTGX N/A
- Revenue Next Year
- ENR $1.63
- PTGX $53.09
- P/E Ratio
- ENR $30.72
- PTGX $61.48
- Revenue Growth
- ENR 0.39
- PTGX N/A
- 52 Week Low
- ENR $19.70
- PTGX $32.50
- 52 Week High
- ENR $39.52
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- ENR 60.50
- PTGX 53.99
- Support Level
- ENR $20.96
- PTGX $49.38
- Resistance Level
- ENR $23.02
- PTGX $51.51
- Average True Range (ATR)
- ENR 0.62
- PTGX 2.02
- MACD
- ENR 0.39
- PTGX -0.39
- Stochastic Oscillator
- ENR 91.72
- PTGX 46.09
About ENR Energizer Holdings Inc.
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.